Form 4: SI-BONE Director Thomas West Receives Equity Grant
Statement of Changes in Beneficial Ownership
Director Thomas A. West was granted 10,957 restricted stock units as part of his compensation for service to SI-BONE, Inc.
Summary
- Director Thomas A. West acquired 10,957 restricted stock units (RSUs) on June 4, 2026.
- Each RSU represents a contingent right to receive one share of SI-BONE, Inc. common stock.
- The grant vests 100% on the earlier of the next annual general meeting or one year from the vesting commencement date, contingent on continued service.
- Following this transaction, the reporting person beneficially owns 37,947 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Standard retention mechanism for board members.
Negatives
- Dilutive effect of new share issuance, though minor in scale.
Risks
- Vesting is subject to the director's continuous service to the company.
Future Outlook
The RSU grant is subject to a one-year vesting schedule, aligning the director's tenure with the company's upcoming annual general meeting cycle.
Industry Context
StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the medical device sector to ensure long-term alignment with shareholder value.
Comparison to Industry Standards
- The use of RSUs for director compensation is consistent with standard practices for mid-cap medical technology companies.
- Vesting periods of one year are typical for non-employee director equity grants in the industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Grant of restricted stock units to a board member. | 2026-06-04 | Neutral; standard alignment of director incentives. |
Stakeholder Impact
- Shareholders: Minor dilution from the issuance of new shares upon vesting.
Next Steps
- Vesting of the 10,957 RSUs upon the next annual general meeting or one year from the vesting commencement date.
Key Dates
| Date | Description |
|---|---|
| 2024-06-07 | Execution date of the Power of Attorney for the reporting person. |
| 2026-06-04 | Date of the RSU grant transaction. |
| 2026-06-08 | Date of filing the Form 4. |
Keywords
SI-BONE, SIBN, Director Compensation, Restricted Stock Units, Insider Transaction, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.